Drug shortages have been acute and widespread this year, but as doctors told STAT, they're nothing new.

October 6, 2023 Check out STAT+

Sponsored By

Adobe Cancer drug shortage eases slightly, but it's still 'living from paycheck to paycheck' A survey shows 86% of cancer centers lack supplies of a generic chemotherapy drug, putting extra strain on children's cases. By Elizabeth Cooney STAT+ | FDA advisory panel signals lack of confidence in data on Amgen's cancer drug Regulatory advisers voted 10-2 that the data on the company's drug Lumakras, a treatment for lung cancer, could not be properly assessed. By Allison DeAngelis STAT+ | 3 questions for the future of Biden's cancer moonshot The original funding for the cancer moonshot has run out. If Congress renews it, it'll have to think hard about the program's future. By John Wilkerson Alex Hogan/STAT The future of health care in the House STAT reviews the health care histories of House Speaker candidates Reps. Steve Scalise (R-La.) and Jim Jordan (R-Ohio). By Rachel Cohrs

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Cancer Briefing? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser